We determined the physiological variability of total cholesterol, high-(HDL) and low-density lipoprotein (LDL) cholesterol, triglycerides, and apolipoproteins A-I and B in fasting blood samples from patients referred to the Johns Hopkins Lipid Referral Clinic. Samples were taken on each of three occasions during baseline evaluation visits before the patients were treated. The median physiological coefficients of variation (CV) were as follows: total cholesterol, 5.0%; triglycerides, 17.8%; HDL cholesterol, 7.1%; LDL cholesterol, calculated from the previous three measurements, 7.8%; and apolipoproteins A-I and B, 7.1% and 6.4%, respectively. There were no significant differences in CVI, between children ( 18 years) and adults (>18 years) for any of the measurements. On the basis of our findings, single measurements in serial samplestakenon threeoccasions suffice to establish the patients' usual values with the following precisions (± 1 CV): total cholesterol, ± 4%; triglycerides, ± 11%; HDL cholesterol, ± 8%; LDL cholesterol, ± 6%; and apolipo- proteins become more widely available, they undoubtedly will also be used for clinical decision making. Upon repeated measures, considerable variability of lipids and lipoproteins has been noted within individuals (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . This variation arises in part from variations in the accuracy and precision of the laboratory methods used to measure these components (analytical variation) but is also largely reflective of the normal biological fluctuations that occur in day-to-day living (physiological variation).
proteins become more widely available, they undoubtedly will also be used for clinical decision making.
Upon repeated measures, considerable variability of lipids and lipoproteins has been noted within individuals (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . This variation arises in part from variations in the accuracy and precision of the laboratory methods used to measure these components (analytical variation) but is also largely reflective of the normal biological fluctuations that occur in day-to-day living (physiological variation).
Criteria for accuracy and precision for the total cholesterol measurement have been defined to identify properly those individuals with an unacceptably high cholesterol concentration (16). The error attributable to the analytical component of variation has been found to contribute less than half the total variability of total cholesterol measurements in normal individuals
(16).

Most of the intra-individual variation in total cholesterol is due to normal biological fluctuations (14, 16).
The National Cholesterol Education Program Laboratory Standardization Panel, assuming a coefficient of analytical variation (CV5) to be 5.0%, and the coefficient of physiological variation (CV) to be about 6.5%, estimated that duplicate measurements obtained in blood samples on at least four occasions would be necessary to determine an individual's "usual" cholesterol concentration with 95% confIdence (16). For practical reasons, however, it was recommended that, as a minimum, single measurements made on at least two occasions could be used for this purpose. This would suffice to establish an individual's usual cholesterol value with a 93% certainty (16).
The information currently available about the normal physiological variability of LDL-C and HDL-C (6, (9) (10) (11) (12) (13) (14) (15) has been obtained for the most part in normal subjects. To our knowledge, the present study is the first to examine physiological variation in a clinical setting in which the physician must establish the patient's usual lipid and lipoprotein concentrations during the course of evaluation and treatment. Here we report the analytical and physiological variability of lipids, lipoprotein cholesterol, and apoA-I and apoB in patients referred for evaluation and treatment of dyslipidemia.
Materials and Methods Study Subjects
Subjects were selected from among patients of the
Johns Hopkins University
Lipid Referral Clinic, a tertiary-care referral clinic specializing in the detection and management of lipid and lipoprotein disorders. Most patients referred to the clinic had seen a dietitian before their referral and were consuming a diet low in saturated fat and cholesterol. The subjects were seen in a standardized format for the first three visits: They were asked to fast for 12 h before each visit, and blood was obtained for the measurement of lipids, lipoprotein cholesterol, and apoA-I and apoB. A history and physical examination and nutritional record were obtained at the first visit. At the second visit (one month later), the subject's usual nutritional intake was reviewed by a dietitian to ensure that the patient was following an American Heart Association Step I diet. Any subject whose dietary fat intake exceeded that recommended by the Step I diet was excluded from this study. Six This left an initial study population of 151 patients. For the purposes of this study, we calculated LDL-C from the measured values of total cholesterol, triglycerides, and HDL-C as described by Friedewald et al. (17) (see below). Because this equation is not used when triglycerides exceed 4.52 mmoIJL, we eliminated another 21 subjects whose triglycerides exceeded 4.52 mmol/L at any visit and 2 subjects for which HDL-C values were missing for one of their three visits. The final study population for total cholesterol, triglycerides, LDL-C, and HDL-C consisted of 128 patients who had a complete lipoprotein profile at all three visits. Of the initial study population of 151 patients, 143 subjects had results for apoA-I and apoB analyses at each of the three visits. For the apolipoproteins, we did not exclude subjects with triglycerides exceeding 4.52 mmol/L.
Lipid andLipoprotein Measurements
Blood was drawn into evacuated collection tubes containing disodium EDTA, For each poo1 we determined the mean and SD, which we then used to calculate the CVa:
We found that for a particular analyte the CV,, values for different quality-control pools were similar (see below). We therefore used the average CVa for the pools as the CV,, for that analyte.
The CVa for LDL-C was estimated from the individual variances for total cholesterol, triglycerides, and HDL-C, because HDL-C was not analyzed in the pools used to measure total cholesterol and triglycerides, so we did not have LDL measurements for the qualitycontrol pools.
The CVa for LDL-C was calculated as follows, assuming that the quantifications of total cholesterol, HDL-C, and triglycerides (TG) were independent measurements: From the Friedewald equation, To provide insight into the range of CV for each sex, and individual within-sex and -age groups.
Comparison of Descriptive Characteristics
Within age categories, the mean ages of males and females were compared by use of Student's t-test. To determine changes in weight across the thi visits, paired t-tests were performed for within-patient differgroups are defined as follows:boys, 1 8 years; men, >18 years;girls, alS years; women, >18 years.
ences in Quetelet Index between visits. Differences in
visit-to-visit time intervals across the four age-sex #{176}Value significantly different (P = 0.01) fromV1 and V2. 
Calculation of CV,
For each analyte, the coefficient of physiological variation, CVI,, was calculated as described by Warnick and Albers (7) . Briefly, we calculated for each subject the mean and variance of the values for the three visits.
This variance, V, represented the total variance for the subject, including the contributions of physiological and groups were evaluated by analysis of variance. In addition, Scheff#{233}'s test was used to test pair-wise comparisons among groups.
All calculations were performed with the SAS program (21) .
Results
The demographic characteristics are shown by age and sex in Table 1 The group mean values for cholesterol, triglycerides, LDL-C, HDL-C, and the two apolipoproteins are presented in Table 2 .
Analytical Variation
The CVa values for cholesterol, triglycerides, HDL-C, and the two apolipoproteins are shown in Table 3 (Table  2) . Based on the average CV,, for the three analytes, the CVa for LDL-C was 4.3%.
Two lyophilized and five frozen pools were analyzed for the apolipoproteins.
For apoA-I, CV, ranged from 4.0% to 7.0%, and for apoB the range of CV,, was 5.0% to 7.7% (Table 3 ). The CV,, for the lyophilized and frozen pools was similar for both apolipoproteins.
On the basis of these results, we used average values of 6.1% (apoA-I) and 6.4% (apoB) for the CV,, for the two apolipoproteins.
Physiological Variation
The median total (CV) and physiological (CV) coefficients of variation are presented in Table 4 for the overall group and for the age-and sex-specific subgroups. There were no significant differences in the total or physiological CVs for total cholesterol, HDL-C, LDL-C, or apoA-I among any of the subgroups studied. In particular, no increase in the variability of these
ever, CV,, might be expected to vary among individuals, the net effect of which is that a single measurement in a patient with a low CV more reliably estimates that patient's "usual" concentration than does a single mea- total cholesterol and the greatest for triglycerides (Table  5) . Also, the distributions of CV,, for LDL-C and apoB, and for HDL-C and apoA-I were superimposable for each of the subgroups (Figure 1 ). This might be expected, because apoB is found primarily in LDL and apoA-I in HDL.
CV,, was also estimated by using a random-effects analysis of variance (20 The median CV for HDL-C for the overall group was 9.6%. Median CV (7.1%) was equal to CV,, (7.2%). Thus, the analytical component of variation contributed substantially to the overall variability of HDL-C measurements. The median CV and CV values for the LDL-C concentration in the overall group were 8.8% and 7.8%, respectively.
The CV for LDL-C exceeded the CV,, (4.3%) by about 1.8-fold.
The median CV and CV,, values for apoA-I were 10.1% and 7.1%, respectively; those for apoB were 8.2%
and 6.4%, respectively.
The physiological fluctuation in apoA-I was therefore equal to that in HDL-C and that for apoB was a little less than for LDL-C (Table 4) .
Cumulative Frequencies of CV
The CV values shown in Table 4 are the medians for the patients and patient subgroups as a whole. How-
Discussion
The analytical and physiological components of total variation were calculated for total cholesterol, triglycerides, HDL-C, LDL-C, and apoA-I and apoB in hyperlipidemic subjects. Most of the patients were physicianreferred and had already made an attempt to modify their saturated fat intake before their initial visit. No substantial changes in dietary fat intake were reported between the first three visits in any of the subjects; however, most subjects reported more conscientious eating habits after the first visit. This could explain, in part, the trend towards more desirable lipid, lipoprotein cholesterol, and apolipoprotein concentrations between visits one and three in the overall group. Mean total cholesterol concentration decreased 3.1% between visits one and three. During this period, triglycerides docreased 8.0%, apoA-I increased 4.6%, and apoB decreased 2.7% (P <0.05). There were no significant changes in HDL-C or LDL-C. In view of these observations, we think it likely that part of the observed variability was due to self-intervention as the patients became more aware of their eating habits with each succeeding visit. However, this is likely to occur in most clinical practices, and the variation observed in our study seems particularly relevant to general medical practice settings.
The total variation in lipids and lipoproteins analyzed in serial samples from a given individual is generally partitioned into two components. The analytical component of variation generally includes pre-ana.lytical factors such as patient preparation, blood drawing, and sample preparation as well as factors related to the 
Physiological CV (%)
arise from a variety of sources that affect lipoprotein Table 5 
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tively-are comparable with previous reports of 1-3% The CV,, we observed for LDL-C (4.3%) was somewhat lower, and closer to the values (4.4-5.2%)
reported by others (11, 14, 15) . The median physiological variabilities of all the analytes except plasma triglycerides were similar. CV,, ranged from 5.0% for total cholesterol to 7.8% for LDL-C and was in the ranges reported by others for free-living normal populations (6, 7, 11, 12, 14, 15) . Those for apoA-I and apoB were similar at 7.1% and 6.4%, respectively, similar to the values reported by Brown Panel recommended that the patient be sampled for cholesterol measurement on at least two different occasions at least one week apart (16). As seen in Table 7 , such a sampling scheme reduces the CV for total cholesterol to 4.1%. Table 7 also reveals, however, that duplicate analyses of three or four separate specimens would be required to reduce the CV, for LDL-C, HDL-C, apoA-I, and apoB concentrations to about 5%, and for triglyceride concentration to 8%. Such extensive analyses would not be practical, for economic and other constraints. On the basis of our findings, however, we recommend that at least three samples be obtained from the patient, each to be analyzed once. Under these conditions, triglycerides would be established with a CV of about 11%; LDL-C, HDL-C, apoA-I, and apoB with CV values of 6% to 8%; and total cholesterol with a CV, of about 3.5% ( Table 9 illustrates the total coefficients of variation for single measurements in each of three serial samples for patients with CV,, values at the 75th percentiles shown in Table 5 . For total cholesterol, which manifests the least physiological variation among the six analytes, measurements in three serial samples would establish the patient's usual cholesterol concentration with an overall precision (CV,) of about 5.6% (Table 9 ), compared with 3.5% for a patient with a median CV,, ( Table 7) . Even for triglycerides, the most variable of the six analytes, three serial samples would suffice to establish the patient's triglyceride concentration with an overall precision of about 16.0% (Table 9) , compared with 11.4% for patients with a median CV,, for triglyc- 
